WNS Extends Contract with GSK to Provide High-end Analytical Services
March 04 2016 - 8:00AM
Business Wire
WNS (Holdings) Limited (NYSE: WNS), a leading provider of global
Business Process Management (BPM) services, today announced that it
has extended its service contract with global pharmaceutical leader
GlaxoSmithKline (GSK) until December, 2020.
“We are extremely proud to renew our agreement with GSK. For
more than a decade, WNS has been a trusted partner driving
evidence-based decisions through high-end research and analytics
services. Under the agreement with GSK, WNS has set up a dedicated
state-of-the-art Knowledge Center, driven by a team of over 600
industry experts. WNS leverages its deep Pharma domain knowledge,
robust analytics capabilities and proprietary frameworks to deliver
actionable business insights to GSK,” said Keshav R. Murugesh,
Group CEO, WNS.
With a team of over 2,500 research and analytics professionals
globally, WNS provides a wide range of analytics services to our
clients across Big Data, marketing, digital, HR, and operations.
These solutions leverage WNS’ deep domain expertise, proprietary
frameworks and technology-enabled capabilities.
About WNS
WNS (Holdings) Limited (NYSE: WNS) is a leading global business
process management company. WNS offers business value to 200+
global clients by combining operational excellence with deep domain
expertise in key industry verticals including Travel, Insurance,
Banking and Financial Services, Manufacturing, Retail and Consumer
Packaged Goods, Shipping and Logistics, Healthcare and Utilities.
WNS delivers an entire spectrum of business process management
services such as finance and accounting, customer care, technology
solutions, research and analytics and industry specific back office
and front office processes. As of December 31, 2015, WNS had 31,340
professionals across 39 delivery centers worldwide including China,
Costa Rica, India, Philippines, Poland, Romania, South Africa, Sri
Lanka, United Kingdom and the United States. For more information,
visit www.wns.com.
Safe Harbor Provision
This document includes information which may constitute
forward-looking statements made pursuant to the safe harbor
provisions of the Private Securities Litigation Reform Act of 1995,
the accuracy of which are necessarily subject to risks,
uncertainties, and assumptions as to future events. Factors that
could cause actual results to differ materially from those
expressed or implied are discussed in our most recent Form 20-F and
other filings with the Securities and Exchange Commission. WNS
undertakes no obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160304005243/en/
WNS (Holdings)
LimitedInvestors:David
MackeyCorporate SVP - Finance & Head of Investor
Relations+1 (201)
942-6261david.mackey@wns.comorMedia:Archana
RaghuramHead – Corporate Communications+91 (22) 4095
2397archana.raghuram@wns.com; pr@wns.com
WNS (NYSE:WNS)
Historical Stock Chart
From May 2024 to Jun 2024
WNS (NYSE:WNS)
Historical Stock Chart
From Jun 2023 to Jun 2024